Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus

OBJECTIVE: Coinfection of tuberculosis (TB) and viral hepatitis may increase the risk of antituberculosis treatment-induced hepatotoxicity, which is regarded as a common cause of termination of the first-line antituberculosis drugs. The study aimed at investigating the protective effects of antivira...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaojing, Zheng, Xiao, Shen, Chenyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577919/
https://www.ncbi.nlm.nih.gov/pubmed/34764998
http://dx.doi.org/10.1155/2021/2884151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577919/
https://www.ncbi.nlm.nih.gov/pubmed/34764998
http://dx.doi.org/10.1155/2021/2884151

Ejemplares similares